PCSA 0.98 (-2.97%)
US74275C2052BiotechnologyBiotechnology

Processa Pharmaceuticals (PCSA) Stock Highlights

0.98 | -2.97%
2024-11-19 06:42:39
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The companys lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100.

Statistics

Range Today
0.98 1.06
Volume Today 27.1K
Range 1 Year
1 17.4
Volume 1 Year 257.49M
Range 3 Year
1 124
Volume 3 Year 265.92M
Range 10 Year
1 2185.4
Volume 10 Year 266.9M

Highlights

Market Capitalization 3.76M (micro)
Floating Shares 2.89M
Current Price 0.98
Price To Earnings -0.23
Price To Book 0.97
Earnings Per Share -5.02
Payout Ratio 0%

Performance

Latest -2.97%
1 Month -27.41%
3 Months -30.5%
6 Months -50.51%
1 Year -88.86%
3 Years -99.21%
5 Years -99.72%
10 Years -99.95%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.